Literature DB >> 1254991

Biological properties of the M-44 strain of Coxiella burneti.

J W Johnson, G A Eddy, C E Pedersen.   

Abstract

The attenuated M-44 strain of Coxiella burneti was investigated for biological characteristics affecting its use as a live vaccine. After 25 serial passages in guinea pigs, the strain did not develop phase I properties detectable by the microagglutination test. Infectious organisms were not detected in untreated guinea pigs later than 12 weeks after inoculation; however, infection could be reactivated at later times by the production of stress (by pregnancy or drug treatment) in guinea pigs that had recovered. Evidence of reactivated infection was observed in recovered pregnant animals just before parturition at 46 weeks after infection, in methyl prednisolone-treated animals at 56 weeks, and in cyclophosphamide-treated guinea pigs at 96 weeks. A low rate of intercage and intracage infection was recorded.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254991     DOI: 10.1093/infdis/133.3.334

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

Authors:  A Moos; T Hackstadt
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 2.  Q fever and Coxiella burnetii: a model for host-parasite interactions.

Authors:  O G Baca; D Paretsky
Journal:  Microbiol Rev       Date:  1983-06

3.  Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain.

Authors:  T A Hoover; D W Culp; M H Vodkin; J C Williams; H A Thompson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection.

Authors:  Andreas Stein; Céline Louveau; Hubert Lepidi; Fanny Ricci; Pascal Baylac; Bernard Davoust; Didier Raoult
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.

Authors:  David M Waag; Marilyn J England; Christopher R Bolt; Jim C Williams
Journal:  Clin Vaccine Immunol       Date:  2008-08-13

6.  Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia.

Authors:  J Kazár; R Brezina; A Palanová; B Tvrdá; S Schramek
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.